MultiOmyx 101: An Introduction to Multiplexing Technology

MultiOmyx multiplex assay reveals increases in tumor-infiltrating lymphocyte density and PD-L1 expression in tumors after oncolytic virotherapy.

The content in the blogs herein relate to the opinions and views expressed by the individual blog author(s) and contributors and are not necessarily the viewpoints held by NeoGenomics Inc., or any of its affiliates or entities.

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients